Antigen Directed Therapy Pre-Transplant Confers Superior Post-Transplant Survival Outcome Compared to Conventional Chemotherapy in Pediatric Patients with Relapsed and Refractory B-ALL

Stiefel, J., Flower, A. M., Botwinick, M., Ford, M., Foti, A., Gandhi, M., Slovin, J., Smilow, E., Bowers, A., Karpel, H., Schwartz, L. Y., Fraint, E., Gennarini, L. M., Gardner, S. L., Raetz, E. A., Shah, N. C., Chen, J., Krajewski, J., Hijiya, N., … Sulis, M. L. (2022). Antigen Directed Therapy Pre-Transplant Confers Superior Post-Transplant Survival Outcome Compared to Conventional Chemotherapy in Pediatric Patients with Relapsed and Refractory B-ALL. Blood, 140(Supplement 1), 7763–7765. https://doi.org/10.1182/blood-2022-160272
Authors:
Jessica Stiefel
Allyson Flower
Marissa Botwinick
Maegan Ford
Alycia Foti
Mital Gandhi
Justin Slovin
Elana Smilow
Ashley Bowers
Hannah Karpel
Leya Schwartz
Ellen Fraint
Lisa Gennarini
Sharon Gardner
Elizabeth A. Raetz
Niketa C. Shah
Jing Chen
Jennifer Krajewski
Nobuko Hijiya
Prakash Satwani
Jessica Hochberg
Audrey Mauguen
Kevin J. Curran
Maria Luisa Sulis
Affiliated Authors:
Maegan Ford
Alycia Foti
Nobuko Hijiya
Prakash Satwani
Publication Type:
Article
Unique ID:
10.1182/blood-2022-160272
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: